| Patient | Roald Amundsen |
|---|---|
| Date of birth | 1872-07-16 |
| Identifiers | MRN HR-EX003-SYN-TD; SSN (made up) 000-03-1259 |
| Document date | 1928-05-05 |
| Author | Ingrid Solheim-Achebe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twelve-week review of finger pain on duloxetine. [S]
Mr. Amundsen returns six weeks after starting duloxetine; he has taken 60 mg daily for five weeks. The mild nausea of the first days has gone, and he has had no drowsiness, dizziness or sweating. His average finger pain over the past week is 3 of 10; the cold attacks are shorter and less frequent, though the spring weather is milder too. He sleeps through most nights. He uses capsaicin cream only on cold days. He can manage buttons and keys outdoors with liner gloves. He did not have the blood test that was meant to be done two to four weeks after starting duloxetine. [S]
| Element | Detail |
|---|---|
| Finger pain | Average 3 of 10 over the past week |
| Medicine effects | Early nausea gone; no drowsiness, dizziness or sweating |
| Sleep | Sleeping through most nights |
| Function | Manages buttons and keys outdoors with liner gloves |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Finger burning in the cold, much less; no dizziness |
| Gastrointestinal | Negative | No nausea now; normal appetite |
| Psychiatric | Negative | Mood better; PHQ-9 3 |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Capsaicin 0.075% cream, a small amount rubbed into the painful fingers four times a day; wash hands after use and keep away from the eyes | four times a day | Topical route | 1928-02-24 | active | S |
| Duloxetine 30 mg delayed-release capsule, one capsule by mouth daily for one week | once daily for one week | Oral route | 1928-03-24 to 1928-03-31 | completed | S |
| Duloxetine 60 mg delayed-release capsule, one capsule by mouth daily; do not stop suddenly | once daily | Oral route | 1928-03-31 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1928-05-05 | Body height | 183 | cm | S |
| 1928-05-05 | Body weight | 78.6 | kg | S |
| 1928-05-05 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1928-05-05 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1928-05-05 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1928-05-05 | Heart rate | 66 | /min | S |
| 1928-05-05 | Respiratory rate | 14 | /min | S |
| 1928-05-05 | Body temperature | 36.6 | Cel | S |
| 1928-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1928-05-05 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1928-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1928-05-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 136-145 mmol/L | Normal | S |
| 1928-05-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-52 U/L | Normal | S |
Vital signs recorded on 1928-05-05; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 132/82, pulse 66, weight 78.6 kg |
| Hands | Fingertips cool; skin intact |
| Neurological | Alert; no tremor |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning pain, numbness and tingling in the fingers of both hands, brought on by cold for many winters and worse this winter, with the fingers turning white then blue then red in the cold; average pain 6 of 10; cause not yet established at intake; nerve conduction studies and neurology consultation requested | resolved | confirmed | R20.2 | S — Synthetic presenting problem anchored to his documented frostbite of the fingers; superseded by the diagnosis at the neurology consultation. |
| Cold-induced neuropathic pain and cold sensitivity of the fingers of both hands, a late sequela of frostbite in early adulthood: small-fiber pattern with normal nerve conduction studies, cold allodynia and reduced pinprick at the fingertips, and cold-induced vasospasm | active | confirmed | M79.2 | S — Synthetic modern diagnosis made at the neurology consultation, linked to his documented frostbite of the fingers. |
| Old fracture of the upper end of the right humerus, set at sea and rehabilitated without surgery: forward flexion and abduction limited to about 120 degrees, without pain at rest | active | confirmed | S42.201S | S — Synthetic modern coding of his documented shoulder fracture; the range of movement is synthetic. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pain severity (0 to 10 numeric rating) and overall improvement | Every review, and early after starting or changing a medicine | Completed today | Average 3 of 10, from 6 at intake |
| Medication safety | Adverse effects, especially drowsiness, dizziness and nausea | Every review, and early after starting or changing a medicine | Completed today | Early nausea only; no drowsiness or dizziness |
| Examination | Daily activities and participation: fine hand tasks in the cold, driving, flying | Every review, and early after starting or changing a medicine | Completed today | Manages fine tasks outdoors with gloves; driving |
| Survey | Mood (PHQ-9) and anxiety | Every review, and early after starting or changing a medicine | Completed today | PHQ-9 3 |
| Examination | Sleep quality | Every review, and early after starting or changing a medicine | Completed today | Sleeping through most nights |
| Examination | Blood pressure | Before starting duloxetine and periodically on it | Completed today | 132/82 mmHg, up from 126/78 before duloxetine; recheck at the next visit |
| Laboratory | Sodium and liver enzyme (ALT) on duloxetine | Baseline, then once in the first weeks of treatment | Completed today | Sodium 139 mmol/L and ALT 27 U/L. Protocol deviation: the test ordered for two to four weeks after starting duloxetine was not drawn, because no date was booked and it was missed at the preventive visit; it was drawn today, six weeks after starting. No harm resulted: both results are normal. Corrective action: book the blood test with a date when a medicine needing monitoring is started |
| Medication safety | Interactions: no tramadol or other serotonergic drugs; caution with oral NSAIDs; alcohol | Every review | Completed today | No new medicines; rare alcohol |
| Self-management | Skin of the fingers and cold protection | Every review, and early after starting or changing a medicine | Completed today | Skin intact |
Goal progress:
Guideline basis: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024)
Follow-up: Review in about five weeks, with a blood pressure check. Next scheduled visit 1928-06-09: seventeen-week review: finger pain, the ankle sprain, and the risks of an Arctic air search flight. [S]